Figure 3From: Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study) Magnetic resonance imaging of the pancreas indicating the circumferential resection margins (bd: bile duct, smv: superior mesenteric vein, arrows indicate pancreatic tail).Back to article page